Moreover, NF-κB is involved in programmed cell death-ligand1 (PD-L1) expression regulation in GBM cells by initiating PD-L1 gene transcription via promoter binding [25], and indirectly influencing PD-L1 transcriptionally, further contributing to T cell inhibition. The gene discussed is NFKB1; the disease is glioblastoma.